Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
AssigneesBaxter International Inc., Hadasit Medical Research Services and Development Ltd.
InventorShimon Slavin
Life of this patent
Estimating the term…
Abstract
A method of treating a human cancer patient having a solid tumor comprising malignant cells is disclosed, wherein the patient having undergone a cancer therapy regimen comprising allogeneic stem cell transplantation. The method comprises administering allogeneic lymphocytes to the patient and monitoring the patient for levels of malignant cells.
Claims16
A method of treating a human cancer patient having a solid tumor comprising malignant cells, said patient having undergone a cancer therapy regimen comprising allogeneic stem cell transplantation, said method comprising:
- a) administering allogeneic lymphocytes to said patient;
- and
- b) monitoring said patient for levels of said malignant cells.
Dependencies are inferred from the claim text.